Formulary
Using the Formulary
Therapeutic Sections
1 Gastro-intestinal system
2 Cardiovascular system
3 Respiratory system
4 Central nervous system
5 Infections
6 Endocrine system
7 Obstetrics, gynaecology, and urinary-tract disorders
8 Malignant disease and immunosuppression
9 Nutrition and blood
10 Musculoskeletal and joint diseases
11 Eye
12 Ear, nose, and oropharynx
13 Skin
14 Immunological products and vaccines
15 Anaesthesia
Drug Index
Kent and Medway Guidance
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory system
4. Central Nervous system
5. Infections
6. Endocrine system
7. Obstetrics, gynaecology and urinary-tract disorders
8. Malignant disease and immunosuppression
9. Nutrition and Blood
10. Musculoskeletal and joint diseases
11. Eye
12. Miscellaneous
13. Care Home Guidance Documents
14. Palliative Care
Appliances
STOMA ACCESSORY PRODUCT FORMULARY
Kent and Medway ICB Newsletters
Medicines Supply (stock shortages)
Shared care guidance
Using the Formulary
Therapeutic Sections
1 Gastro-intestinal system
1.1 Dyspepsia and gastro-oesophageal reflux disease
1.1.2 Compound alginates and proprietary indigestion preparations
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.3.1 H2-receptor antagonists
1.3.5 Proton pump inhibitors
Chelates and Complexes
1.4 Acute diarrhoea
1.4.2 Antimotility drugs
1.5 Chronic bowel disorders
1.5.1 Aminosalicylates
1.5.2 Corticosteroids
1.5.3 Drugs affecting the immune response
1.6 Laxatives
1.6.1 Bulk-forming laxatives
1.6.2 Stimulant laxatives
1.6.4 Osmotic laxatives
1.6.5 Bowel cleansing preparations
1.6.6 Peripheral opioid-receptor antagonists
1.6.7 Other drugs used in constipation
1.7 Local preparations for anal and rectal disorders
1.7.2 Compound haemorrhoidal preparations with corticosteroids
1.7.3 Rectal sclerosants
1.7.4 Management of anal fissures
1.9 Drugs affecting intestinal secretions
1.9.1 Drugs affecting biliary composition and flow
1.9.2 Bile acid sequestrants
1.9.4 Pancreatin
2 Cardiovascular system
2.1 Positive inotropic drugs
2.1.1 Cardiac glycosides
2.2 Diuretics
2.2.1 Thiazides and related diuretics
2.2.2 Loop diuretics
2.2.3 Potassium-sparing diuretics and aldosterone antagonists
2.2.4 Potassium-sparing diuretics with other diuretics
2.2.5 Osmotic diuretics
2.2.6 Non-steroidal mineralocortoid receptor antagonists
2.3 Anti-arrhythmic drugs
2.3.2 Drugs for arrhythmias
2.4 Beta-adrenoceptor blocking drugs
2.5 Hypertension and heart failure
2.5.1 Vasodilator antihypertensive drugs
2.5.2 Centrally acting antihypertensive drugs
2.5.4 Alpha-adrenoceptor blocking drugs
2.5.5 Drugs affecting the renin-angiotensin system
2.5.3 SGLT2 inhibitor (Heart Failure)
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6.1 Nitrates
2.6.2 Calcium-channel blockers
2.6.3 Other antianginal drugs
2.6.4 Peripheral vasodilators and related drugs
2.7 Sympathomimetics
2.7.1 Inotropic sympathomimetics
2.7.2 Vasoconstrictor sympathomimetics
2.7.3 Cardiopulmonary resuscitation
2.8 Anticoagulants and protamine
2.8.1 Parenteral anticoagulants
2.8.2 Oral anticoagulants
2.8.3 Protamine sulfate
2.9 Antiplatelet drugs
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.10.2 Fibrinolytic drugs
2.11 Antifibrinolytic drugs and haemostatics
2.12 Lipid-regulating drugs
2.13 Anticoagulant reversal agents
3 Respiratory system
3.1 Bronchodilators
3.1.1 Adrenoceptor agonists
3.1.2 Antimuscarinic bronchodilators
3.1.3 Theophylline
3.1.4 Compound bronchodilator preparations
3.1.5 Peak flow meters, inhaler devices and nebulisers
3.2 Corticosteroids
Corticosteroids (Intranasal)
3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
3.3.2 Leukotriene receptor antagonists
3.3.3 Phosphodiesterase type-4 inhibitors
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4.1 Antihistamines
3.4.2 Allergen immunotherapy
3.4.3 Allergic emergencies
3.5 Respiratory stimulants and pulmonary surfactants
3.5.1 Respiratory stimulants
3.5.2 Pulmonary surfactants
3.6 Oxygen
3.7 Mucolytics
3.9 Cough preparations
3.9.1 Cough suppressants
3.9.2 Demulcent and expectorant cough preparations
3.10 Systemic nasal decongestants
3.11 Antimuscarinics
4 Central nervous system
4.1 Hypnotics and anxiolytics
4.1.1 Hypnotics
4.1.2 Anxiolytics
4.2 Drugs used in psychoses and related disorders
4.2.1 Antipsychotic drugs
4.2.2 Antipsychotic depot injections
4.2.3 Drugs used for mania and hypomania
4.3 Antidepressant drugs
4.3.1 Tricyclic and related antidepressant drugs
4.3.2 Monoamine-oxidase inhibitors
4.3.3 Selective serotonin re-uptake inhibitors
4.3.4 Other antidepressant drugs
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.6 Drugs used in nausea and vertigo
4.7 Analgesics
4.7.1 Non-opioid analgesics and compound analgesic preparations
4.7.2 Opioid analgesics
4.7.3 Neuropathic pain
4.7.4 Antimigraine drugs
4.8 Antiepileptic drugs
4.8.1 Control of the epilepsies
4.8.2 Drugs used in status epilepticus
4.9 Drugs used in parkinsonism and related disorders
4.9.1 Dopaminergic drugs used in Parkinson's disease
4.9.2 Antimuscarinic drugs used in parkinsonism
4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders
4.10 Drugs used in substance dependence
4.10.1 Alcohol dependence
4.10.2 Nicotine dependence
4.10.3 Opioid dependence
4.11 Dementia
Multiple sclerosis
5 Infections
5.1 Antibacterial drugs
5.1.1 Penicillins
5.1.2 Cephalosporins, carbapenems, and other beta-lactams
5.1.3 Tetracyclines
5.1.4 Aminoglycosides
5.1.5 Macrolides
5.1.6 Clindamycin
5.1.7 Some other antibacterials
5.1.8 Sulfonamides and trimethoprim
5.1.9 Antituberculosis drugs
5.1.11 Metronidazole and tinidazole
5.1.12 Quinolones
5.1.13 Urinary-tract infections
5.2 Antifungal drugs
5.2.1 Triazole antifungals
5.2.3 Polyene antifungals
5.2.4 Echinocandin antifungals
5.2.5 Other antifungals
5.3 Antiviral drugs
5.3.1 HIV infection
5.3.2 Herpesvirus infections
5.3.3 Viral hepatitis
5.3.4 Influenza
5.3.5 Respiratory syncytial virus
5.4 Antiprotozoal drugs
5.4.1 Antimalarials
5.4.2 Amoebicides
5.4.4 Antigiardial drugs
5.4.5 Leishmaniacides
5.4.8 Drugs for pneumocystis pneumonia
5.5 Anthelmintics
5.5.1 Drugs for threadworms
5.5.5 Schistosomicides
6 Endocrine system
6.1 Drugs used in diabetes
6.1.1 Insulins
6.1.2 Antidiabetic drugs
6.1.4 Treatment of hypoglycaemia
6.1.6 Diagnostic and monitoring devices for diabetes mellitus
6.1.7 Blood Glucose Test Strips
6.1.8 Blood Ketone Test Strips
6.1.9 Diabetes Hypodermic Equipment
6.2 Thyroid and antithyroid drugs
6.2.1 Thyroid hormones
6.2.2 Antithyroid drugs
6.3 Corticosteroids
6.3.1 Replacement therapy
6.3.2 Glucocorticoid therapy
6.4 Sex hormones
6.4.1 Female sex hormones and their modulators
6.4.2 Male sex hormones and antagonists
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens
6.5.2 Posterior pituitary hormones and antagonists
6.6 Drugs affecting bone metabolism
6.6.1 Calcitonin and parathyroid hormone
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
6.7 Other endocrine drugs
6.7.1 Bromocriptine and other dopaminergic drugs
6.7.2 Drugs affecting gonadotrophins
7 Obstetrics, gynaecology, and urinary-tract disorders
7.1 Drugs used in obstetrics
7.1.1 Prostaglandins and oxytocics
7.1.2 Mifepristone
7.1.3 Myometrial relaxants
7.2 Treatment of vaginal and vulval conditions
7.2.1 Preparations for vaginal and vulval changes
7.2.2 Vaginal and vulval infections
7.3 Contraceptives
7.3.1 Combined hormonal contraceptives
7.3.2 Progestogen-only contraceptives
7.3.3 Spermicidal contraceptives
7.3.4 Contraceptive devices
7.3.5 Emergency contraception
7.4 Drugs for genito-urinary disorders
7.4.1 Drugs for urinary retention
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
7.4.3 Drugs used in urological pain
7.4.4 Bladder instillations and urological surgery
7.4.5 Drugs for erectile dysfunction
7.4.6 Premature Ejaculation
Uterine disorders
8 Malignant disease and immunosuppression
8.1 Cytotoxic drugs
8.1.1 Alkylating drugs
8.1.2 Anthracyclines and other cytotoxic antibiotics
8.1.3 Antimetabolites
8.1.4 Vinca alkaloids and etoposide
8.1.5 Other antineoplastic drugs
8.2 Drugs affecting the immune response
8.2.1 Antiproliferative immunosuppressants
8.2.2 Corticosteroids and other immunosuppressants
8.2.3 Anti-lymphocyte monoclonal antibodies
8.2.4 Other immunomodulating drugs
8.3 Sex hormones and hormone antagonists in malignant disease
8.3.1 Oestrogens
8.3.2 Progestogens
8.3.3 Androgens
8.3.4 Hormone antagonists
9 Nutrition and blood
9.1 Anaemias and some other blood disorders
9.1.1 Iron-deficiency anaemias
9.1.2 Drugs used in megaloblastic anaemias
9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias
9.1.4 Drugs used in platelet disorders
9.1.5 G6PD deficiency
9.1.6 Drugs used in neutropenia
9.2 Fluids and electrolytes
9.2.1 Oral preparations for fluid and electrolyte imbalance
9.2.2 Parenteral preparations for fluid and electrolyte imbalance
9.4 Oral nutrition
9.4.1 Foods for special diets
9.4.2 Enteral nutrition
9.5 Minerals
9.5.1 Calcium and magnesium
9.5.2 Phosphorus
9.5.3 Fluoride
9.5.4 Zinc
9.6 Vitamins
9.6.2 Vitamin B group
9.6.4 Vitamin D
9.6.5 Vitamin E
9.6.6 Vitamin K
9.6.7 Multivitamin preparations
9.7 Bitters and tonics
9.8 Metabolic disorders
9.8.1 Drugs used in metabolic disorders
Platelet disorders
10 Musculoskeletal and joint diseases
10.1 Drugs used in rheumatic diseases and gout
10.1.1 Non-steroidal anti-inflammatory drugs
10.1.2 Corticosteroids
10.1.3 Drugs that suppress the rheumatic disease process
10.1.4 Gout and cytotoxic-induced hyperuricaemia
10.2 Drugs used in neuromuscular disorders
10.2.1 Drugs that enhance neuromuscular transmission
10.2.2 Skeletal muscle relaxants
10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief
10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices
11 Eye
11.3 Anti-infective eye preparations
11.3.1 Antibacterials
11.3.3 Antivirals
11.4 Corticosteroids and other anti-inflammatory preparations
11.4.1 Corticosteroids
11.4.2 Other anti-inflammatory preparations
11.5 Mydriatics and cycloplegics
11.6 Treatment of glaucoma
11.7 Local anaesthetics
11.8 Miscellaneous ophthalmic preparations
11.8.1 Tear deficiency, ocular lubricants, and astringents
11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment
Retinal Disorders
12 Ear, nose, and oropharynx
12.1 Drugs acting on the ear
12.1.1 Otitis externa
12.1.3 Removal of earwax
Otitis Media
12.2 Drugs acting on the nose
12.2.1 Drugs used in nasal allergy
12.2.2 Topical nasal decongestants
12.2.3 Nasal preparations for infection
12.3 Drugs acting on the oropharynx
12.3.1 Drugs for oral ulceration and inflammation
12.3.2 Oropharyngeal anti-infective drugs
12.3.3 Lozenges and sprays
12.3.4 Mouthwashes, gargles, and dentifrices
12.3.5 Treatment of dry mouth
13 Skin
13.2 Emollient and barrier preparations
13.2.1 Emollients
13.2.2 Barrier preparations
13.3 Topical local anaesthetics and antipruritics
13.4 Topical corticosteroids
13.5 Preparations for eczema and psoriasis
13.5.2 Preparations for psoriasis
13.6 Acne and rosacea
13.6.1 Topical preparations for acne
13.6.2 Oral preparations for acne
13.7 Preparations for warts and calluses
13.9 Shampoos and other preparations for scalp and hair conditions
13.10 Anti-infective skin preparations
13.10.1 Antibacterial preparations
13.10.2 Antifungal preparations
13.10.3 Antiviral preparations
13.10.4 Parasiticidal preparations
13.10.5 Preparations for minor cuts and abrasions
13.11 Skin cleansers, antiseptics, and desloughing agents
13.11.1 Alcohols and saline
13.11.2 Chlorhexidine salts
13.11.4 Iodine
13.11.6 Oxidisers and dyes
13.12 Antiperspirants
13.13 Topical circulatory preparations
14 Immunological products and vaccines
14.4 Vaccines and antisera
14.5 Immunoglobulins
14.5.1 Normal immunoglobulin
14.6 International travel
15 Anaesthesia
15.1 General anaesthesia
15.1.1 Intravenous anaesthetics
15.1.2 Inhalational anaesthetics
15.1.3 Antimuscarinic drugs
15.1.4 Sedative and analgesic peri-operative drugs
15.1.5 Neuromuscular blocking drugs
15.1.6 Drugs for reversal of neuromuscular blockade
15.1.7 Antagonists for central and respiratory depression
15.1.8 Drugs for malignant hyperthermia
15.2 Local anaesthesia
High Cost Drugs Manual
Drug Index
Kent and Medway Guidance
1. Gastro-intestinal system
2. Cardiovascular system
Bempedoic acid guidance
K&M DOAC Monitoring Recommendations for Non-Valvular Atrial Fibrillation (NVAF) in Primary Care.
NICE guidance for AF
Lipid Management Pathway
K&M Anticoagulant position statement and risk mitigation principles
Dapagliflozin and Empagliflozin in heart failure
Kent & Medway ICB Position Statement for prescribing Inclisiran
3. Respiratory system
COPD
Adrenaline auto injectors
Asthma guidelines
4. Central Nervous system
ADHD
Lidocaine
Management of Adults with Headaches and Migraines in Primary Care
Melatonin
Opioids
Lithium Treatment Care Pathway
Dementia Prescribing Guideline for GPs
5. Infections
Supplementary pages for K&M antimicrobial prescribing guidance
Accessing Treatment for CDI in Primary Care
Summary of antimicrobial prescribing guidance-managing common infections
Kent and Medway Back-up (delayed) Antibiotic Prescribing Guidance
Aims and Principles of Antimicrobial Treatment
Teicoplanin SDEC dosing schedule
6. Endocrine system
Armour Thyroid
Liothyronine documents
Dapaglifoxin in CKD guidance
KM Guidelines for the Management of Type 2 Diabetes in Adults
Kent and Medway HRT prescribing guideline
Kent & Medway Guidance on Safe Insulin Prescribing
7. Obstetrics, gynaecology and urinary-tract disorders
Overactive Bladder Pathway in Women
Dapoxetine for premature ejaculation (PE)
8. Malignant disease and immunosuppression
Multiple sclerosis
9. Nutrition and Blood
Infant Formula
Vitamin D (3)
K&M ICB Vitamin B12 position statement
Oral Nutritional Supplements
Hypomagnesaemia in Adults – Primary Care Guide
Kent and Medway ICB Forceval - Position Statement for Primary Care
10. Musculoskeletal and joint diseases
Denosumab Shared Care Guidance
Methotrexate K&M position statement
DMARDS Shared Care Guidance
11. Eye
Dry eyes
12. Miscellaneous
Repeat Prescribing Duration Recommendation
National patient safety alert-implementing the steroid emergency card
Information on prescriptions issued after a private consultation
Over the Counter Guidance Documents
Position Statement on mixing private and NHS treatment.
Guidance for the management of free of charge/manufacturer discounted medicine schemes
Kent and Medway Position Statement: Safe Prescribing of Injectable Medicines in Primary Care
Sharps Bin Collection and Replacement guide and Sharps Bin Prescribing Guide
13. Care Home Guidance Documents
Care Homes Best Practice Guidance Documents
Critical Medicines List for Care Homes
Integrated Care Document Package
A Guide to Implementing EMIS Proxy Access for Care Homes
14. Palliative Care
KM Palliative Care Guidance
Appliances
STOMA ACCESSORY PRODUCT FORMULARY
Search
Contact details
Kent and Medway ICB Newsletters
Medicines Supply (stock shortages)
Shared care guidance
9.4.1 Foods for special diets
9.4.2 Enteral nutrition
Preferred
On Formulary
Specialist Initiation
Hospital Use Only
Unlicensed Medicines
